SEC Comment Letter for FIBROGEN INC (FGEN) (CIK 0000921299) (KYNB) — May 3, 2022
FIBROGEN INC (FGEN) (CIK 0000921299)
Date: May 3, 2022 · CIK: 0000921299 · Accession: 0000000000-22-004853
AI Filing Summary & Sentiment
File numbers found in text: 001-36740
Letter
United States securities and exchange commission logo May 3, 2022 Pat Cotroneo Chief Financial Officer FibroGen, Inc. 409 Illinois Street San Francisco, CA 94158 Re:FibroGen, Inc. Form 10-K for the Fiscal Year Ended December 31, 2020 Filed March 1, 2021 File No. 001-36740 Dear Mr. Cotroneo: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Juan Graham
Show Raw Text
United States securities and exchange commission logo
May 3, 2022
Pat Cotroneo
Chief Financial Officer
FibroGen, Inc.
409 Illinois Street
San Francisco, CA 94158
Re:FibroGen, Inc.
Form 10-K for the Fiscal Year Ended December 31, 2020
Filed March 1, 2021
File No. 001-36740
Dear Mr. Cotroneo:
We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Juan Graham